GREEN CROSS LAB CELL

green-cross-lab-cell-logo

GC Green Cross Their goal is to contribute to the healthy life of mankind and become a global leader in the healthcare industry. Recent advances in biotechnology have become a good foundation for achieving their goals. The paradigm of medicine is changing. They are shifting from traditional medicines and synthetic medicines to biopharmaceutical development. GC Green Cross Cellular gene therapy, which is the main pipeline of LAPSEL, is expected to enable the treatment of rare and intractable dis... eases as well as cancer, because of the fundamental treatment of diseases at the gene and cell level. In particular, successful cases such as approval of the first immunotherapeutic drug (CAR-T) in 2017 and the approval of the first gene therapy (Luxturna) were epoch-making events that transformed the expectations they had in mind into reality. Is added.

#SimilarOrganizations #Financial #More

GREEN CROSS LAB CELL

Industry:
Biotechnology

Status:
Active

Contact:
82 3 1260 9600

Technology used in webpage:
Apache Korea Telecom


Similar Organizations

lutris-pharma-logo

Lutris Pharma

Lutris Pharma develops drugs to improve anti-cancer therapy effectiveness.

Stock Details


Company's stock symbol is KOSDAQ:144510

Acquisitions List

Date Company Article Price
2021-07-16 GC Cell GC Cell acquired by Green Cross Lab Cell N/A

Investments List

Date Company Article Money raised
2021-02-26 Artiva Biotherapeutics Green Cross Lab Cell investment in Series B - Artiva Biotherapeutics 120 M USD
2020-06-26 Artiva Biotherapeutics Green Cross Lab Cell investment in Series A - Artiva Biotherapeutics 78 M USD

More informations about "Green Cross Lab Cell"

Green Cross Lab Cell - Crunchbase Investor Profile

Development. GC Green Cross Cellular gene therapy, which is the main pipeline of LAPSEL, is expected to enable the treatment of rare and intractable diseases as well as cancer, because of the fundamental treatment of diseases at the โ€ฆSee details»

Green Cross Lab Cell and C&R Research Signs Joint โ€ฆ

Oct 30, 2019 GCCL will be a subsidiary of GC Lab Cell, with GC Lab Cell and C&R Research as its major shareholders of 67% and 26.1%, respectively. GCCL will serve as a central laboratory that analyzes biosamples (human biologicals โ€ฆSee details»

KOREA LIFE SCIENCE WEEK

GC Cell was reborn as joint corporation of Koreaโ€™s leading cell therapy companies, GC Green Cross Cell and GC Green Cross Lab Cell, for a new leap forward. GC Cell is leading the โ€ฆSee details»

Green Cross LabCell Corporation (GC LabCell) (KRX: 114510)

Its subsidiary, Green Cross LabCell is focused on clinical development of MG4101, a random donor PBMC-derived, ex vivo expanded and activated NK cell product in a number of Phase II โ€ฆSee details»

Green Cross Lab Cell - Investments, Portfolio & Company Exits

Green Cross Lab Cell has acquired GC Cell on Jul 16, 2021. Unlock for free . Investments. Edit Investments Section. Number of Investments 2. Green Cross Lab Cell has made 2 โ€ฆSee details»

Green Cross Lab Cell Corporation entered into a definitive merger ...

Jul 15, 2021 Green Cross Lab Cell Corporation (KOSDAQ:A144510) entered into a definitive merger agreement to acquire Green Cross Cell Corporation (KOSDAQ:A031390) from a group โ€ฆSee details»

GC Cell Corporation Stock - MarketScreener.com

Nov 22, 2024 GC Cell Corp formerly Green Cross Lab Cell Corp is a Korea-based company principally engaged in the provision of specimen testing services. The Company operates its โ€ฆSee details»

Green Cross Lab Cell acquires GC Cell - 2021-07-16 - Crunchbase

Jul 16, 2021 GC Cell GC Cell specialize in cell therapy, obtained approval for its developed Immunecell-LC as a liver cancer immunotherapy agent in 2007. Acquiring Organization: Green โ€ฆSee details»

Green Cross Lab Cell Corporation completed the acquisition of โ€ฆ

Oct 26, 2021 Green Cross Lab Cell Corporation entered into a definitive merger agreement to acquire Green Cross Cell Corporation from a group of shareholders for approximately KRW โ€ฆSee details»

Grifols to acquire Green Cross plasma fractionation facility in ...

Jul 20, 2020 The volumetric proportion of red blood cells in the blood. This value is obtained by performing a blood test in a laboratory. The normal hematocrit values depend on the โ€ฆSee details»

Green Cross Lab Cell - Funding, Financials, Valuation & Investors

Green Cross Lab Cell Corporation develops cell therapy products.See details»

Green Cross Labcell joins US$1.8 bln deal to develop cancer drug

SEOUL, Jan. 29 (Yonhap) -- A subsidiary of South Korean pharmaceutical firm Green Cross Corp. said Friday it has participated in a partnership deal worth US$1.8 billion to develop โ€ฆSee details»

LABORATORY CORPORATION OF AMERICA NPI 1205272622 โ€ฆ

May 13, 2013 NPI Profile for Laboratory Corporation Of America in 2022 Opitz Blvd Woodbridge, Va 22191. Phone: (703) 707-2262 . Taxonomy 291U00000X Accepts: Blue Cross and Blue โ€ฆSee details»

Grifols closes the acquisition of Green Cross fractionation plant in ...

Oct 1, 2020 The volumetric proportion of red blood cells in the blood. This value is obtained by performing a blood test in a laboratory. The normal hematocrit values depend on the โ€ฆSee details»

Schedule Pickup - GreenDrop

GreenDrop makes it convenient to donate your lightly used clothing, household items and other goods to a nonprofit with our free home donation pickup program. Schedule now!See details»

Green Cross Lab Cell Corporation completed the acquisition of โ€ฆ

Oct 26, 2021 Green Cross Lab Cell Corporation (KOSDAQ:A144510) entered into a definitive merger agreement to acquire Green Cross Cell Corporation (KOSDAQ:A031390) from a group โ€ฆSee details»

Find a Plasma Donation Center | Donate Plasma to Red Cross

During a plasma-only donation, blood is drawn from one arm and sent through a high-tech machine that collects your plasma and then safely and comfortably returns your red cells and โ€ฆSee details»

SubCellBarCode: Proteome-wide Mapping of Protein ... - Cell Press

Jan 3, 2019 Orre et al. use mass spectrometry to map the subcellular localization of more than 12,000 proteins across several cell lines and present a method for proteome-wide โ€ฆSee details»

Kleo Pharmaceuticals Enters into Research Collaboration with โ€ฆ

Mar 31, 2020 Green Cross Lab Cell Corporation completed the acquisition of Green Cross Cell Corporation from a group of shareholders. 21-10-26: CI Green Cross Lab Cell Corporation โ€ฆSee details»

linkstock.net © 2022. All rights reserved